Diabetes prevention needs to account for diet-microbiota interactions, because some gut microbes appear to predict diabetes risk differently depending on fiber intake.
William Fusco, Policlinico Gemelli, discusses the gut fermentation syndrome, a rare condition arising when ethanol-producing bacteria or fungi in the gut generate excessive amounts of alcohol from dietary carbohydrates.
Monitoring or reshaping the gut microbiota after adenoma removal could become part of future strategies to reduce colorectal cancer risk.
Repeated head impacts, even if minor, can have biological effects.
Guy Boeckxstaens of KU Leuven explains how mast cells may alter pain signalling through IgE dependent responses to food antigens and activation of the MRGPRX2 receptor.
The results may inform programs to preserve microbial diversity while delivering essential care.
Targeting deoxycholic acid (DCA)-producing gut bacteria could be a way to slow breast cancer progression.
Nathalie Vergnolle (Inserm, France) discussed the potential role of proteases in altering the intestinal mucus layer in irritable bowel syndrome (IBS).
Microbiota-derived molecules such as IPA may offer a way to strengthen early-life immunity against respiratory viruses.
Monitoring the gut microbiota could in the future help understand, diagnose, or manage Sjögren syndrome.
